Christoph Faul

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Journal: Leukemia & lymphoma

Published: August 02, 2026

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

Journal: Journal of hematology & oncology

Published: March 31, 2026

Humoral responses to SARS-CoV-2 vaccination in allogeneic hematopoietic cell transplantation patients resemble that of healthy individuals.

Humoral responses to SARS-CoV-2 vaccination in allogeneic hematopoietic cell transplantation patients resemble that of healthy individuals.

Journal: Frontiers in immunology

Published: March 12, 2026

IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.

Journal: Blood

Published: August 04, 2025

IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.

IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.

Journal: Blood

Published: August 04, 2025

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Journal: Blood advances

Published: July 15, 2025

Extensive non-clonal CAR T-cell expansion causing fatal hyperinflammatory syndrome with immune effector cell-associated hemophagocytic lymphohistiocytosis, cytokine release syndrome, and neurotoxicity syndrome.

Extensive non-clonal CAR T-cell expansion causing fatal hyperinflammatory syndrome with immune effector cell-associated hemophagocytic lymphohistiocytosis, cytokine release syndrome, and neurotoxicity syndrome.

Journal: Haematologica

Published: May 17, 2025

New X for VEXAS: haploidentical allogeneic haematopoietic cell transplantation in VEXAS syndrome.

New X for VEXAS: haploidentical allogeneic haematopoietic cell transplantation in VEXAS syndrome.

Journal: Rheumatology (Oxford, England)

Published: March 28, 2025

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution.

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution.

Journal: Blood advances

Published: November 13, 2024

Allogeneic Hemopoietic Cell Transplantation as a Paradigm for Cellular Immunotherapy.

Allogeneic Hemopoietic Cell Transplantation as a Paradigm for Cellular Immunotherapy.

Journal: Oncology research and treatment

Published: November 01, 2024

Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantation.

Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: October 26, 2024

Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A.

Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A.

Journal: Blood advances

Published: September 10, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026